• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Dyspnea (1816); Fatigue (1849); Restenosis (4576)
Event Date 12/06/2022
Event Type  Injury  
Event Description
It was reported that angina occurred.Diagnostic coronary angiography revealed a 90% stenosed target lesion at the ostial to proximal segment of the right coronary artery.The lesion was treated with rotational atherectomy followed by dilation with a non-boston scientific balloon.Intravascular lithotripsy was completed with a non-boston scientific balloon.A 4.50 x 15 emerge was selected to treat the lesion followed by laser atherectomy.Optical coherence tomography revealed a large degree of dissected neointimal tissue and a 4.00 x 48 synergy was deployed.The stent was post-dilated with a 4.50 x 12 non-compliant balloon and brachytherapy was performed.Post revascularization, 10% residual stenosis with thrombolysis in myocardial infarction (timi) flow 3 was noted.After the procedure, the patient experienced minor right sided chest discomfort.
 
Event Description
It was reported that angina occurred.On (b)(6) 2022 diagnostic coronary angiography revealed a 90% stenosed target lesion at the ostial to proximal segment of the right coronary artery.The lesion was treated with rotational atherectomy followed by dilation with a non-boston scientific balloon.Intravascular lithotripsy was completed with a non-boston scientific balloon.A 4.50 x 15 emerge was selected to treat the lesion followed by laser atherectomy.Optical coherence tomography revealed a large degree of dissected neointimal tissue and a 4.00 x 48 synergy was deployed.The stent was post-dilated with a 4.50 x 12 non-compliant balloon and brachytherapy was performed.Post revascularization, 10% residual stenosis with thrombolysis in myocardial infarction (timi) flow 3 was noted.After the procedure, the patient experienced minor right sided chest discomfort.It was further reported that on (b)(6) 2023 subject started experiencing cardiac symptoms associated with shortness of breath and dyspnea without chest pain.Diagnostic coronary angiography revealed 80% ostial stenosis of the rca and the subject was diagnosed with coronary artery diseases and aortic stenosis.On (b)(6) 2023 the subject presented with worsening symptoms of shortness of breath and fatigue.A coronary artery bypass graft procedure was performed to treat the stenosis.The subject also had an aortic valve replacement for the severe aortic stenosis.On (b)(6) 2023 the coronary artery disease and aortic stenosis were considered resolved, but the shortness of breath and fatigue persisted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key16404994
MDR Text Key309860693
Report Number2124215-2023-07685
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age59 YR
Patient SexFemale
Patient RaceWhite
-
-